Article
Multivariate Survival Analysis of a Comprehensive Clinical Trial of Rapamycin in Amyotrophic Lateral Sclerosis Explores Prognostic Factors and Survival Patterns in C9orf72 Carriers.
European journal of neurology - 1 Sept 2026
De Nardi Alex, Paris Alessio, Lauria Mario, Martinelli Ilaria, Zucchi Elisabetta, Simonini Cecilia, Mandrioli Jessica, Marchetti Luca
Abstract excerpt
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease marked by considerable variability in survival times. This retrospective study aims to evaluate the prognostic value of a broad range of variables by conducting a comprehensive survival analysis on longitudinal data from RAP-ALS, a clinical trial investigating the effects of rapamycin in ALS patients (n = 63). METHODS:...
Read the complete abstract on PubMedTopics
- Humans
- Amyotrophic Lateral Sclerosis
- C9orf72 Protein
- Female
- Male
- Prognosis
